Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-014002·FibroBiologics, Inc.
Schedule 13G ownership disclosure
FIBROBIOLOGICS INC
Common Stock, $0.00001 par value · CUSIP: 31573L105
Event date: 2024-08-09
- Filing-level shares
- 2,134,853.00
- Percent of class
- 5.579%
- Mike Newlin
Shares: 2,134,853.00 · Class: 5.579%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-014002
- Form type
- SCHEDULE 13G
- Filer
- FibroBiologics, Inc.
- CIK
- CIK 1958777
- Filed
- Jun 06, 2025
- Reporting period
- Aug 09, 2024
- Description
- Schedule 13G beneficial ownership